QuikClot is a company specializing in providing bleeding control systems using their proprietary technology, which consists of a non-woven material impregnated with kaolin. Their products are designed to address bleeding scenarios from abrasions to traumatic injuries by accelerating the clotting cascade, thus leading to faster bleeding control. The company was founded in 2002 and is based in the United States.
QuikClot is a part of Teleflex, a global provider of medical technologies focused on improving the health and quality of people’s lives. Teleflex is known for its diversity of solutions in various medical fields including vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine, and respiratory care. Teleflex houses several trusted brands, including QuikClot, united by a common sense of purpose. For more information, visit www.Teleflex.com.
As of now, there is no available data regarding the last investment in QuikClot or the involved investors. The company operates in the manufacturing and medical devices industries.